Collins Questions Top Pharmaceutical Companies at HELP Hearing to Address Insulin Affordability
May 13, 2023
May 13, 2023
WASHINGTON, May 13 -- Sen. Susan M. Collins, R-Maine, issued the following news release on May 12, 2023:
U.S. Senator Susan Collins, a member of the Health, Education, Labor and Pensions (HELP) Committee and co-chair of the Diabetes Caucus, questioned top pharmaceutical companies at a hearing titled, 'The Need to Make Insulin Affordable for All Americans'. Senator Collins noted that current practices in the insulin market are rife with perverse incentives and are opaque, e . . .
U.S. Senator Susan Collins, a member of the Health, Education, Labor and Pensions (HELP) Committee and co-chair of the Diabetes Caucus, questioned top pharmaceutical companies at a hearing titled, 'The Need to Make Insulin Affordable for All Americans'. Senator Collins noted that current practices in the insulin market are rife with perverse incentives and are opaque, e . . .